Go Pro
OTCMKTS:RADLY

Raia Drogasil (RADLY) Stock Price, News & Analysis

Raia Drogasil logo
$3.75 -0.05 (-1.32%)
As of 10:54 AM Eastern

About Raia Drogasil Stock (OTCMKTS:RADLY)

Advanced

Key Stats

Today's Range
$3.75
$3.75
50-Day Range
$3.25
$4.00
52-Week Range
$3.08
$5.34
Volume
2,362 shs
Average Volume
70,983 shs
Market Capitalization
$4.93 billion
P/E Ratio
N/A
Dividend Yield
1.07%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Raia Drogasil, now operating under the brand name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a nationwide network of pharmacies that sells prescription and over-the-counter medicines, personal-care products, cosmetics, health and wellness items, and convenience products.

The company also provides digital shopping and delivery services through its online channels, supporting customers with medication and health-related purchases. Its operations combine physical stores with e-commerce and other healthcare-related services, serving consumers throughout Brazil.

RD Saúde was formed in 2011 through the merger of Drogasil and Droga Raia, two pharmacy chains with roots dating back to the early twentieth century. The company is headquartered in São Paulo and continues to operate its principal retail banners under the Raia and Drogasil names.

AI Generated. May Contain Errors.

Raia Drogasil Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
42nd Percentile Overall Score

RADLY MarketRank™: 

Raia Drogasil scored higher than 42% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Raia Drogasil has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Raia Drogasil has received no research coverage in the past 90 days.

  • Read more about Raia Drogasil's stock forecast and price target.
  • Earnings Growth

    Earnings for Raia Drogasil are expected to grow by 41.18% in the coming year, from $0.17 to $0.24 per share.

  • Price to Book Value per Share Ratio

    Raia Drogasil has a P/B Ratio of 3.75. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Raia Drogasil's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the float of Raia Drogasil has been sold short.
  • Short Interest Ratio / Days to Cover

    Raia Drogasil has a short interest ratio ("days to cover") of 0.12, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Raia Drogasil has recently decreased by 82.29%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Raia Drogasil has a dividend yield of 0.94%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Raia Drogasil does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Raia Drogasil will have a dividend payout ratio of 16.67% next year. This indicates that Raia Drogasil will be able to sustain or increase its dividend.

  • Read more about Raia Drogasil's dividend.
  • News Sentiment

    Raia Drogasil has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Consumer Staples companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Raia Drogasil this week, compared to 0 articles on an average week.
Receive RADLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Raia Drogasil and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RADLY Stock News Headlines

Raia Drogasil SA ADR RADLY
A councilman backed AI — then 13 bullets hit his front door
Thirteen bullets hit an Indianapolis councilman's front door days after he backed a data center rezoning. Across the country, protests, lawsuits, and moratoria are targeting AI infrastructure projects. Whitney Tilson, former hedge fund manager and editor of Stansberry's Investment Advisory, says November 4 could bring this conflict to a head, with major implications for investors' portfolios.tc pixel
Raia Drogasil SA ADR (RADLY)
See More Headlines

RADLY Stock Analysis - Frequently Asked Questions

Raia Drogasil's stock was trading at $4.6520 at the beginning of 2026. Since then, RADLY shares have decreased by 19.4% and is now trading at $3.75.

Raia Drogasil S.A. (OTCMKTS:RADLY) issued its quarterly earnings results on Tuesday, August, 4th. The company reported $0.05 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.05. The business had revenue of $2.17 billion for the quarter, compared to the consensus estimate of $2.32 billion. Raia Drogasil had a net margin of 2.97% and a trailing twelve-month return on equity of 18.20%.

Raia Drogasil shares split on Monday, May 22nd 2023.The 26-25 split was announced on Monday, May 22nd 2023. The newly minted shares were issued to shareholders after the market closes on Monday, May 22nd 2023. An investor that had 100 shares of stock prior to the split would have 104 shares after the split.

Shares of RADLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/04/2026
Today
9/16/2026
Next Earnings (Estimated)
11/03/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Consumer Staples Distribution & Retail
Sub-Industry
N/A
Current Symbol
OTCMKTS:RADLY
CIK
N/A
Fax
N/A
Employees
57,708
Year Founded
2011

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$232.27 million
Net Margins
2.97%
Pretax Margin
3.34%
Return on Equity
18.20%
Return on Assets
5.32%

Debt

Debt-to-Equity Ratio
0.99
Current Ratio
1.41
Quick Ratio
0.58

Sales & Book Value

Annual Sales
$7.93 billion
Price / Sales
0.62
Cash Flow
$0.46 per share
Price / Cash Flow
8.16
Book Value
$1.00 per share
Price / Book
3.75

Miscellaneous

Outstanding Shares
1,315,250,000
Free Float
N/A
Market Cap
$4.93 billion
Optionable
Not Optionable
Beta
N/A

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (OTCMKTS:RADLY) was last updated on 9/16/2026 by MarketBeat.com Staff.
From Our Partners